Canadian life sciences company Ondine Biomedical, known for its groundbreaking work in light-activated antimicrobial treatments, has confirmed that its innovative Steriwave technology will be piloted by King's College Hospital (KCH), one of London's key teaching hospitals and a global pioneer in healthcare innovation. This initiative is part of KCH's commitment to quality improvement with a…